Ionis Pharmaceuticals IONS Current Income Tax Expense (Benefit)
Current Income Tax Expense (Benefit) at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CurrentIncomeTaxExpenseBenefit.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's current income tax expense (benefit).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's current income tax expense (benefit)?
- Ionis Pharmaceuticals (IONS) reported current income tax expense (benefit) of $446.5K in Q4 2025.
- How has Ionis Pharmaceuticals's current income tax expense (benefit) changed year-over-year?
- Ionis Pharmaceuticals's current income tax expense (benefit) increased by 128.9% year-over-year, from -$1.54M to $446.5K.
- What is the long-term trend for Ionis Pharmaceuticals's current income tax expense (benefit)?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's current income tax expense (benefit) has grown at a -76.5% compound annual growth rate (CAGR), from $32.32M to $1.79M.
- What does current income tax expense (benefit) mean?
- The total income tax expense or benefit that is currently payable or refundable.
- How do you interpret current income tax expense (benefit)?
- A high current tax expense relative to pre-tax income may indicate limited tax planning or lack of available tax credits.
- How does current income tax expense (benefit) compare across companies?
- A fundamental metric in the income tax provision note for all companies.